CMPS · Compass Pathways Plc ADR
United States · RS rating 62 · As of 2026-10-14
| Price | 11.27 USD |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 13 / 33 / 94 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 37 / 32 / 39 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +30.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +25.8% |
| Market cap (USD) | $1.2B |